Kinetic and in silico studies of hydroxy-based inhibitors of carbonic anhydrase isoforms I and II
Özet
A series of hydroxy and phenolic compounds have been assayed for the inhibition of two physiologically relevant carbonic anhydrase (CA, EC 4.2.1.1) isozymes, the cytosolic human isozymes I and II. The investigated molecules showed inhibition constants in the range of 1.07-4003 and 0.09-31.5 μM at the hCA I and hCA II enzymes, respectively. In order to investigate the binding mechanisms of these inhibitors, in silico studies were also applied. Molecular docking scores of the studied compounds are compared using three different scoring algorithms, namely Glide/SP, Glide/XP and Glide/IFD. In addition, different ADME (absorption, distribution, metabolism and excretion) analysis was performed. All the examined compounds were found within the acceptable range of pharmacokinetic profiles.
Anahtar Kelimeler
- Scopus
- 10
- WoS
- 11
- OpenAlex
- 15
Tam Kayıt
| Alan | Değer | Dil |
|---|---|---|
| dc.contributor.author | Ekhteiari Salmas, Ramin | |
| dc.contributor.author | Mestanoglu, Mert | |
| dc.contributor.author | Durdagi, Serdar | |
| dc.contributor.author | Sentürk, Murat | |
| dc.contributor.author | Kaya, A. Afşin | |
| dc.contributor.author | Kaya, Elif Çelenk | |
| dc.date.accessioned | 2026-10-22T10:23:47.697279514Z | |
| dc.date.available | 2026-10-22T10:23:47.697279514Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | A series of hydroxy and phenolic compounds have been assayed for the inhibition of two physiologically relevant carbonic anhydrase (CA, EC 4.2.1.1) isozymes, the cytosolic human isozymes I and II. The investigated molecules showed inhibition constants in the range of 1.07-4003 and 0.09-31.5 μM at the hCA I and hCA II enzymes, respectively. In order to investigate the binding mechanisms of these inhibitors, in silico studies were also applied. Molecular docking scores of the studied compounds are compared using three different scoring algorithms, namely Glide/SP, Glide/XP and Glide/IFD. In addition, different ADME (absorption, distribution, metabolism and excretion) analysis was performed. All the examined compounds were found within the acceptable range of pharmacokinetic profiles. | |
| dc.identifier.doi | 10.3109/14756366.2014.1003216 | |
| dc.identifier.eissn | 1475-6374 | |
| dc.identifier.endpage | 37 | |
| dc.identifier.issn | 1475-6366 | |
| dc.identifier.issue | 1 | |
| dc.identifier.pmid | 25676327 | |
| dc.identifier.scopus | 2-s2.0-84953275064 | |
| dc.identifier.startpage | 31 | |
| dc.identifier.uri | https://rdlopen.rawdatalibrary.net/r/gumushane/15261 | |
| dc.identifier.volume | 31 | |
| dc.identifier.wos | WOS:000367555300004 | |
| dc.language.iso | en | |
| dc.publisher | Taylor and Francis Ltd | |
| dc.relation.ispartof | Journal of Enzyme Inhibition and Medicinal Chemistry | |
| dc.rights | info:eu-repo/semantics/openAccess | |
| dc.subject | ADME | |
| dc.subject | CA inhibitors | |
| dc.subject | carbonic anhydrase | |
| dc.subject | molecular docking simulations | |
| dc.subject.classification | Biochemistry & Molecular Biology | |
| dc.subject.classification | Chemistry, Medicinal | |
| dc.subject.classification | Pharmacology & Pharmacy | |
| dc.subject.other | Algorithms | |
| dc.subject.other | Carbonic Anhydrase Inhibitors | |
| dc.subject.other | Carbonic Anhydrases | |
| dc.subject.other | Computer Simulation | |
| dc.subject.other | Dose-Response Relationship, Drug | |
| dc.subject.other | Humans | |
| dc.subject.other | Isoenzymes | |
| dc.subject.other | Kinetics | |
| dc.subject.other | Molecular Docking Simulation | |
| dc.subject.other | Molecular Structure | |
| dc.subject.other | Phenols | |
| dc.subject.other | Structure-Activity Relationship | |
| dc.subject.other | bamipine | |
| dc.subject.other | bromhexine | |
| dc.subject.other | carbonate dehydratase I inhibitor | |
| dc.subject.other | carbonate dehydratase II inhibitor | |
| dc.subject.other | carbonate dehydratase inhibitor | |
| dc.subject.other | diphenylpyraline | |
| dc.subject.other | nepinalone | |
| dc.subject.other | tramadol | |
| dc.subject.other | unclassified drug | |
| dc.subject.other | carbonate dehydratase | |
| dc.subject.other | isoenzyme | |
| dc.subject.other | phenol derivative | |
| dc.subject.other | Article | |
| dc.subject.other | computer model | |
| dc.subject.other | crystal structure | |
| dc.subject.other | drug absorption | |
| dc.subject.other | drug excretion | |
| dc.subject.other | drug metabolism | |
| dc.subject.other | drug synthesis | |
| dc.subject.other | human | |
| dc.subject.other | hydrophobicity | |
| dc.subject.other | inhibition constant | |
| dc.subject.other | molecular docking | |
| dc.subject.other | priority journal | |
| dc.subject.other | structure activity relation | |
| dc.subject.other | algorithm | |
| dc.subject.other | antagonists and inhibitors | |
| dc.subject.other | chemical structure | |
| dc.subject.other | chemistry | |
| dc.subject.other | dose response | |
| dc.subject.other | metabolism | |
| dc.subject.other | synthesis | |
| dc.title | Kinetic and in silico studies of hydroxy-based inhibitors of carbonic anhydrase isoforms I and II | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| rdl.citation.openalex | 15 | |
| rdl.citation.scopus | 10 | |
| rdl.citation.wos | 11 | |
| rdl.department | e School of Health, Gumushane University , Gumushane , Turkey | |
| rdl.oa.status | bronze | |
| rdl.oa.url | https://www.tandfonline.com/doi/pdf/10.3109/14756366.2014.1003216?needAccess=true | |
| rdl.scopus.quartile | Q2 | |
| rdl.sdg | SDG03 | |
| rdl.source.index | SCOPUS | |
| rdl.source.index | WOS | |
| rdl.source.index | PUBMED | |
| rdl.wos.index | Science Citation Index Expanded (SCI-EXPANDED) |

